Vlad Vitoc
Algemeen Directeur bij MAIA BIOTECHNOLOGY, INC.
Vermogen: 5 M $ op 31-05-2024
Profiel
Dr. Vlad Vitoc is a Chairman, President & Chief Executive Officer at MAIA Biotechnology, Inc. and a Chief Executive Officer & Director at DGD Pharmaceuticals Corp.
He is on the Board of Directors at DGD Pharmaceuticals Corp.
He received his MBA from the University of South Carolina and a doctorate degree from Iuliu Hatieganu University of Medicine & Pharmacy.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MAIA BIOTECHNOLOGY, INC.
4.67% | 26-04-2024 | 1 019 121 ( 4.67% ) | 5 M $ | 31-05-2024 |
Actieve functies van Vlad Vitoc
| Bedrijven | Functie | Begin |
|---|---|---|
| MAIA BIOTECHNOLOGY, INC. | Algemeen Directeur | 03-08-2018 |
DGD Pharmaceuticals Corp.
 DGD Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology DGD Pharmaceuticals engages in the development of drug for cancer therapies. It offers DGD1202, targets cancer cell and help prevent to mutate into EGFR. The company was founded by Mukesh Nyati and is headquartered in Chicago, IL. | Algemeen Directeur | - |
Opleiding van Vlad Vitoc
| Iuliu Hatieganu University of Medicine & Pharmacy | Doctorate Degree |
| University of South Carolina | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MAIA BIOTECHNOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
DGD Pharmaceuticals Corp.
DGD Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology DGD Pharmaceuticals engages in the development of drug for cancer therapies. It offers DGD1202, targets cancer cell and help prevent to mutate into EGFR. The company was founded by Mukesh Nyati and is headquartered in Chicago, IL. | Health Technology |
